isoxazoles has been researched along with Candidiasis, Invasive in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bocanegra, R; Duncanson, FP; Everson, MP; Fothergill, AW; Kirkpatrick, WR; McCarthy, DI; Najvar, LK; Olivo, M; Patterson, TF; Wiederhold, NP | 1 |
1 other study(ies) available for isoxazoles and Candidiasis, Invasive
Article | Year |
---|---|
The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicans.
Topics: Aminopyridines; Animals; Antifungal Agents; Candida albicans; Candidiasis, Invasive; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Fluconazole; Isoxazoles; Lipopeptides; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 2015 |